Douglas K. Bratton, 10% Owner at Denali Therapeutics Inc. (DNLI), sold 2,216,798 shares at $65.00 ($144.1M) on 2021-02-12, disclosed to the SEC on 2021-02-17.
Open-market sale of $144.1M DNLI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JUNO | SELL | 2015-07-02 | $2.2M | — | Filing → |
| JUNO | SELL | 2015-06-25 | $13.8M | — | Filing → |
| JUNO | BUY | 2014-12-24 | $15.0M | — | Filing → |